Skip to Main Content
Centers for Disease Control and Prevention link     Centers for Disease Control and Prevention & Smallpox Centers for Disease Control and Prevention link CDC Smallpox Home
Smallpox Vaccination and Adverse Events Training Module - Reactions Links & Site Map Adverse Reactions link Normal Reactions link All Reactions link Site Map link
Side Navigation Menu & Copyright 2002 CDC/HHS Home Page link Smallpox link About the Vaccine link Contraindications link Vaccination Method link Preventing Contact Transmission link Vaccinia Immune Globulin link; Laboratory Testing link Continuing Education link Contact link

Eczema Vaccinatum: Clinical Manifestations

Frequency link Pathogenesis link Clinical link Diagnosis link Management link Prevention link General Info link Eczema Vaccinatum Menu





 
Click here to Zoom Typical umbilicated papules of vaccinia
Back  1 of   Next    Zoom    View All

Click on image to enlarge



Report Adverse Event link Report Adverse Event link

The individual lesions appear identical to a primary vaccination and undergo identical evolution. Because most individuals have large contiguous patches of skin in the affected areas, confluent lesions are the rule. These often cover the entire face, antecubital fossa or behind the knee in the popliteal fossa. Confluent lesions may also appear on other areas of the body. Individual lesions may occur as a result of autoinoculation after the initial transfer, or by viremic spread. 

Untreated patients become quite ill and evidence systemic symptoms. If unrecognized and untreated, the patient will manifest severe systemic symptoms resembling septic shock, and death ensues.

Bacterial infection of the lesions may occur. The lesions will appear similar to those described under Bacterial Infection of Site, but will be more extensive and necrotic. Bacteremia and septicemia may result from local contamination or frank infection of the site, at which time the patient will experience fever, chills, obtundation, and even coma. Abscesses may occur by extension from infected sites. 

Successfully treated individuals will heal as with normal primary vaccinations, with evolution of the individual lesions through the scarring phase. Scarring may be extensive depending on extent of the infected area and the normal tendency for the body to clear the lesions by scar formation.





 
Accidental Administration link Inadvertent Inoculation link Bacterial Infection link Congenital Vaccinia link Eczema Vaccinatum link Encephalitis link Erythema Multiforme link Generalized Vaccinia link Normal Primary link Normal Variants link Progressive Vaccinia link Vaccinia Keratitis link Revaccination link All Reactions links